Thrombosis in children

• References

• 1 Richardson MW, Allen GA, Monahan PE. Thrombosis in children: current perspective and distinct challenges. Thromb Haemost 2002; 88: 900-11.
• 2 Avcin T, Cimaz R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002; 11: 4-10.
• 3 Avcin T, Ambrozic A, Kuhar M. et al. Anticardiolipin and anti-β₂ glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 2001; 40: 565-73.
• 4 Male C, Lechner K, Eichinger S. et al. Clinical significance of lupus anticoagulants in children. J Pediatr 1999; 134: 199-205.
• 5 Seaman DE, Londino V, Kwoh CK. et al. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 1995; 96: 1040-5.
• 6 Berube C, Mitchell L, Silverman E. et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 1998; 44: 351-6.
• 7 Ambrozic A, Avcin T, Ichikawa K. et al. Anti-β₂-glycoprotein I antibodies in children with atopic dermatitis. Int Immunol 2002; 14: 823-30.
• 8 Sammaritano LR, Ng S, Sobel R. et al. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum 1997; 40: 1998-20060.